ALEXANDRIA, Va., Sept. 1 -- United States Patent no. 12,723,086, issued on Sept. 1, was assigned to Nanjing Leads Biolabs Co. Ltd. (Nanjing, China). "Antibodies binding 4-1BB and uses thereof" was in... Read More
ALEXANDRIA, Va., Sept. 1 -- United States Patent no. 12,723,087, issued on Sept. 1, was assigned to Momenta Pharmaceuticals Inc. (Titusville, N.J.). "Anti-FcRn antibodies and methods for treating mya... Read More
ALEXANDRIA, Va., Sept. 1 -- United States Patent no. 12,723,088, issued on Sept. 1, was assigned to Agency for Science, Technology and Research (Singapore). "Antigen binding molecules and methods the... Read More
ALEXANDRIA, Va., Sept. 1 -- United States Patent no. 12,723,089, issued on Sept. 1, was assigned to The Brigham and Women's Hospital Inc. (Boston). "KLRB1 binding agents and methods of use thereof" w... Read More
ALEXANDRIA, Va., Sept. 1 -- United States Patent no. 12,723,090, issued on Sept. 1, was assigned to The Brigham and Women's Hospital Inc. (Boston). "KLRB1 binding agents and methods of use thereof" w... Read More
ALEXANDRIA, Va., Sept. 1 -- United States Patent no. 12,723,091, issued on Sept. 1, was assigned to DIZAL (JIANGSU) PHARMACEUTICAL Co. LTD. (Shanghai). "Anti-FGFR2B antibodies" was invented by Mei Wa... Read More
ALEXANDRIA, Va., Sept. 1 -- United States Patent no. 12,723,092, issued on Sept. 1, was assigned to KAOHSIUNG MEDICAL UNIVERSITY (Kaohsiung City, Taiwan). "Anti-CXCR2 antibodies and uses thereof" was... Read More
ALEXANDRIA, Va., Sept. 1 -- United States Patent no. 12,723,093, issued on Sept. 1, was assigned to Newsoara Biopharmaceutical Technology (Suzhou) Co. Ltd. (JiangSu, China). "TL1A-binding molecules, ... Read More
ALEXANDRIA, Va., Sept. 1 -- United States Patent no. 12,723,094, issued on Sept. 1, was assigned to Regents of the University of Minnesota (Minneapolis). "Anti-DR5 polypeptides and methods of use the... Read More
ALEXANDRIA, Va., Sept. 1 -- United States Patent no. 12,723,095, issued on Sept. 1, was assigned to MERUS N.V. (Utrecht, Netherlands). "Methods of treating cancer using binding molecules that bind CD... Read More